Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection

Status

Withdrawn

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00265408

Enrollment

Registered

2005-12-14

Start date

2005-12-31

Completion date

2007-03-31

Last updated

2014-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Keywords

Cervicocephalic Arterial Dissection

Brief summary

Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection.

Detailed description

20 patients with cervicocephalic arterial dissection will be randomized to open-label aspirin or warfarin, rate of stroke and adverse events will be endpoints.

Interventions

DRUGaspirin

DRUGwarfarin

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Clinical and imaging diagnosis of cervicocephalic arterial dissection within 3 months.

Exclusion criteria

* Any contraindication to aspirin or warfarin.

Design outcomes

Primary

Measure	Time frame
Incidence of stroke by one year.	1 year

Secondary

Measure	Time frame
Recurrent dissection by one year.	1 year
Incidence of TIA by one year.	1 year
Incidence of major and minor bleeding episodes by one year.	1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026